Home Subjects Approval

Approval

TUV Rheinland extends A2LA Accreditation and FCC Approvals in Asia-Pacific’s most important markets

Addition of labs in Guangzhou and Shanghai in China, along with Bangalore in India will help customers meet the wireless, EMI and EMC testing and certification requirements for products aimed at the North American market Bengaluru, January 14, 2018: TUV Rheinland...

Opening of New Medical Colleges

New Delhi, March 15, 2018: As per information provided by Medical Council of India, there are a total 10,41,395 allopathic doctors registered with the State Medical Councils/Medical Council of India as on 30th September, 2017. Assuming 80% availability, it is...

Genzyme’s Lemtrada Approved by the FDA

New Delhi, November 18, 2014 - Genzyme, a Sanofi company, announced that the U.S. Food and Drug Administration (FDA) has approved LemtradaTM (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis (MS). “The approval is the...

CCI Approves The Proposed Merger Between Sun Pharma And Ranbaxy Subject To Modification

New Delhi 09, Dec 2014:The Competition Commission of India (Commission) in its meeting held on 5th December, 2014 (05.12.2014) approved the proposed merger between Sun Pharma and Ranbaxy, subject to the parties inter alia carrying out the divestiture of...

Hetero, Natco get DCGI nod for Hepatitis C drug Sofosbuvir

Hyderabad, Mar 13,2015: Hyderbad-based Hetero and Natco companies on Thursday announced that they have received approval for generic Sofosbuvir tablets, 400 mg, from the Drug Controller General of India. Hetero will launch Sofosbuvir under its brand Sofovir in India. Hetero will...

Jubilant Life receives ANDA approval for Amantadine Hydrochloride Tablets

Mumbai, February 10, 2018: Pharma Major,Jubilant Pharma said that its wholly owned subsidiary Jubilant Life Sciences' material has received Abbreviated New Drug Application (ANDA) final endorsement for Amantadine Hydrochloride Tablets, 100 mg, the generic version of Symmetrel of Endo,...

Cabinet approves MoU between India and Iran on cooperation in the field of...

New Delhi, March 16, 2018: The Union Cabinet chaired by Prime Minister Shri Narendra Modi has given its ex-post-facto approval for the Memorandum of Understanding (MoU) between India and Iran on cooperation in the field of Health and Medicine....

Biocon, Mylan’s Biosimilar Trastuzumab gets ANVISA’s approval

Mumbai, Janaury 04, 2018: Biotechnology mAJOR, Biocon and Mylan have received approval for Biosimilar Trastuzumab from ANVISA, the Brazilian regulatory agency, through their partner Libbs Farmaceutica (Libbs), a leading Brazilian pharmaceutical company. Co-developed by Biocon and Mylan, this is the first...

TGA Australia APPROVAL OPENS UP AUSTRALIAN MARKETS FOR AMANTA HEALTHCARE

Ahmedabad, May 06, 2016: Amanta Healthcare, India’s leading manufacturer and marketer of sterile dosages and Blow-Fill-Seal (BFS) specialist, opens a new chapter in Australia with the award of the Therapeutic Goods Administration (TGA) approval for Sterile Water For Injections...

WuXi STA first CDMO to support the approval of an innovative drug in China...

WuXi STA enables Ascletis to receive NDA Approval from China FDA for Ganovo® Shanghai, June 15, 2018: STA Pharmaceutical Co., Ltd. (WuXi STA), a subsidiary of WuXi AppTec, announces that its partner, Ascletis has received approval from China Food and Drug Administration...